[DOI] [PubMed] [Google Scholar] 56.Perovic D., Kolenc D., Bilic V., Somun N., Drmic D., Elabjer E., Buljat G., Seiwerth S., Sikiric P
PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity
Semaglutide GLP-1 , originally developed for managing type 2 diabetes, has proven effective in aiding weight loss
All the experiments were conducted in accordance with the Italian and European Community law for the use of experimental animals and with the approval of the National Bioethical Committee (approval number: 195/2023-PR)
On stability, the literature describes the following picture: lyophilized peptide is considered stable for months at minus 20 degrees Celsius
